GlassScriptPhysician profile
Tracy Cox Griffith
NPI 1386712560
$5,430.54
in general payments reported to CMS, 2019-2025
27 companies · $1,407 in 2025
The $1,407 reported for 2025 was more than what 90% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $107 · 2022: $649 · 2023: $1,244 · 2024: $2,025 · 2025: $1,407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,674.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,061.35 | 2021-2025 | Lynparza, Calquence, Enhertu |
| Pfizer INC. | $530.66 | 2022-2025 | |
| Stemline Therapeutics INC. | $455.13 | 2023-2024 | Orserdu |
| Kite Pharma, INC. | $251.41 | 2024-2025 | Yescarta |
| Takeda Pharmaceuticals U.S.A., INC. | $236.79 | 2023-2024 | Livtencity, Ninlaro |
| Glaxosmithkline, LLC. | $218.78 | 2023-2024 | Arexvy, Ojjaara |
| Janssen Biotech, INC. | $195.26 | 2024-2025 | Carvykti, Rybrevant, Darzalex |
| Seagen INC. | $193.56 | 2022-2023 | Tukysa |
| Intuitive Surgical, INC. | $177.10 | 2022-2025 | |
| Gilead Sciences, INC. | $172.08 | 2023-2024 | Trodelvy |
| Abbvie INC. | $158.44 | 2024 | |
| Ferring Pharmaceuticals INC. | $148.38 | 2024 | Rebyota |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $129.31 | 2024 | Caplyta |
| Merck Sharp & Dohme LLC | $125.00 | 2025 | Keytruda |
| Immunogen, INC. | $125.00 | 2024 | Elahere |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $121.65 | 2024 | |
| Sun Pharmaceutical Industries INC. | $121.65 | 2024 | |
| Pharmacosmos Therapeutics INC. | $120.76 | 2025 | Monoferric |
| Emd Serono, INC. | $116.19 | 2025 | |
| Lilly USA, LLC | $111.28 | 2025 | |
| Eisai INC. | $106.60 | 2024 | |
| Agios Pharmaceuticals, INC. | $102.88 | 2023 | Pyrukynd |
| Amgen INC. | $96.25 | 2023 | Kyprolis |
| Caris Mpi, INC. | $95.27 | 2025 | Mi Cancer Seek |
| Alnylam Pharmaceuticals INC. | $91.26 | 2024 | Givlaari |
| Olympus America INC. | $88.26 | 2025 | Single Use Grasping Forceps |
| Ambu INC. | $80.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.